Jingnan Wang

Chinese Academy Of Medical Sciences And Peking Union Medical College, 10021
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Correction: Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.

Correction: Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 19, 2025

Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis.

Association of overall survival benefit of radiotherapy with progression-free survival after chemotherapy for diffuse large B-cell lymphoma: A systematic review and meta-analysis.

Journal: Journal of the National Cancer Center

Published: February 07, 2024

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs.

Making the Best Use of Available Weapons for the Inevitable Rivalry-Resistance to EGFR-TKIs.

Journal: Biomedicines

Published: January 25, 2023

Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in immunotherapy.

Integrated pathological analysis to develop a Gal-9 based immune survival stratification to predict the outcome of lung large cell neuroendocrine carcinoma and its usefulness in immunotherapy.

Journal: International journal of biological sciences

Published: July 08, 2022

The Significance of Tumor Microenvironment Score for Breast Cancer Patients.

The Significance of Tumor Microenvironment Score for Breast Cancer Patients.

Journal: BioMed research international

Published: February 10, 2022

Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.

Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.

Journal: Clinical nuclear medicine

Published: April 16, 2019

First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer.

First-in-human study of 177Lu-EB-PSMA-617 in patients with metastatic castration-resistant prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 19, 2018

Response to Single Low-dose 177Lu-DOTA-EB-TATE Treatment in Patients with Advanced Neuroendocrine Neoplasm: A Prospective Pilot Study.

Response to Single Low-dose 177Lu-DOTA-EB-TATE Treatment in Patients with Advanced Neuroendocrine Neoplasm: A Prospective Pilot Study.

Journal: Theranostics

Published: March 06, 2018

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.

Cisplatin-activated PAI-1 secretion in the cancer-associated fibroblasts with paracrine effects promoting esophageal squamous cell carcinoma progression and causing chemoresistance.

Journal: Cell death & disease

Published: February 23, 2018

TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.

TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.

Journal: Journal of molecular medicine (Berlin, Germany)

Published: September 03, 2017

Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.

Rabdocoestin B exhibits antitumor activity by inducing G2/M phase arrest and apoptosis in esophageal squamous cell carcinoma.

Journal: Cancer chemotherapy and pharmacology

Published: August 12, 2017

The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation.

The therapeutic effects of Longikaurin A, a natural ent-kauranoid, in esophageal squamous cell carcinoma depend on ROS accumulation and JNK/p38 MAPK activation.

Journal: Toxicology letters

Published: June 06, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026